Funders › MA › Alzheimer's Disease Research Foundation › 2018

Grants paid by Alzheimer's Disease Research Foundation, tax year 2018

EIN 52-2396428 · Wellesley Hls, MA · Form 990, Schedule I · NTEE H83

In tax year 2018, Alzheimer's Disease Research Foundation (EIN 52-2396428) reported 67 grants paid totaling $15,720,439. Dataset version 2026.09.0, built 2026-09-03.

20182019 2020 2021 2022 2023 2024 2025

Every grant, 2018

Grants reported by Alzheimer's Disease Research Foundation for tax year 2018
Tax year	Recipient	Match	Amount	Type	Purpose	Source filing
2018	Massachusetts General Hospital Boston, MA	A	$1,725,000	paid	ALZHEIMER'S GENOME PROJECT	201901159349300235
2018	The Rockefeller University New York, NY	A	$517,500	paid	DISCOVERY OF CHEMICAL COMPOUNDS THAT INDUCE DEGRADATION OF APP-B-CTF IN CELLS	201901159349300235
2018	Massachusetts Institute of Technology Cambridge, MA	A	$460,000	paid	FUNCTIONAL ANALYSIS OF AD RISK GENES USING HUMAN INDUCED PLURIPOTENT STEM CELLS	201901159349300235
2018	The University of California San Diego La Jolla, CA	U	$373,750	paid	PHARMACOLOGICALLY PROTECTING AND RESCUING SYNAPSES FROM BETA AMYLOID BY RAISING SYNAPTIC PSD-95 HEAD	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$345,000	paid	HIGH THROUGH PUT DRUG SCREENING FOR AD USING 3D HUMAN NEURAL CULTURE SYSTEMS	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$345,000	paid	NEUROPROTECTIVE EFFECTS OF THE EXERCISE HORMONE IRISIN IN AD	201901159349300235
2018	University of Southern California Los Angeles, CA	A	$345,000	paid	THE ROLE OF PICALM MUTATIONS IN AD	201901159349300235
2018	Washington University St Louis St Louis, MO	U	$300,000	paid	UNDERSTANDING THE EFFECT OF APOE ON TAU-MEDIATED NEURODENERATION	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$300,000	paid	UNDERSTANDING HUMAN BRAIN RESILIENCE TO ALZHEIMER'S PATHOLOGY	201901159349300235
2018	University of Southern California Los Angeles, CA	A	$300,000	paid	PICALM GENE THERAPY AND DRUG SCREENING FOR AMYLOID BETA CLEARANCE	201901159349300235
2018	Boston Childrens Hospital Boston, MA	A	$299,924	paid	MICROGLIAL HETEROGENEITY AND TRANSCRIPTIONAL STATE CHANGES IN ALZHEIMER'S DISEASE	201901159349300235
2018	The University of California San Diego La Jolla, CA	U	$287,500	paid	AD RELATED MUTATIONS IN PROTEIN KINASE C	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$287,500	paid	ROLE OF ATXN1 IN REGULATING BACE1 ACTIVITY	201901159349300235
2018	Houston Methodist Hospital Foundation Houston, TX	A	$287,500	paid	UNCOVERING THE MOLECULAR MECHANISM OF SELECTED DRUG CANDIDATES DERIVED FROM SYSTEMATIC ALZHEIMER'S DRUG REPOSITIONING	201901159349300235
2018	The Regents of the University of California Oakland, CA	A	$250,000	paid	INTERPRETATION OF NON-CODING RISK ALLELES OF AD	201901159349300235
2018	Brigham and Women's Hospital Boston, MA	A	$250,000	paid	THE ROLE OF APOE IN MICROGLIA REGULATION IN NEURODEGENERATION	201901159349300235
2018	Mayo Clinic Jacksonville Jacksonville, FL	A	$250,000	paid	APOE: BU YEAR 2	201901159349300235
2018	Washington University St Louis St Louis, MO	U	$250,000	paid	APOE PROTEOFORMS IN HUMAN CNS AND VALIDATION OF TRANSLATIONAL APOE PHARMACODYNAMIC MARKERS	201901159349300235
2018	The Rockefeller University New York, NY	A	$250,000	paid	IMPACT OF APOE AND SEX ON VULNERABLE NEURON-SPECIFIC FUNCTIONAL NETWORKS	201901159349300235
2018	New York University School of Medicine New York, NY	C	$250,000	paid	NEUROTOXIC REACTIVE ASTROCYES IN ALZHEIMER'S DISEASE	201901159349300235
2018	Harvard College Boston, MA	A	$250,000	paid	ANALYTICAL AND STATISTICAL TOOLS FOR SEQUENCE ANALYSIS FOR ALZHEIMER'S DISEASE	201901159349300235
2018	Harvard College Boston, MA	A	$250,000	paid	ASSESSING THE LINKS BETWEEN THE MS4A RISK GENESE, MICROGLIA, AND ALZHEIMER'S DISEASE	201901159349300235
2018	University of Michigan Ann Arbor, MI	U	$241,738	paid	2018 PAULSON GIORDANI HAMPSTEAD	201901159349300235
2018	University of Virginia Charlottesville, VA	U	$230,000	paid	MENINGEAL LYMPHATIC FUNCTION AND ANTIBODY THERAPY IN AD	201901159349300235
2018	University of Virginia Charlottesville, VA	U	$230,000	paid	CELL CYCLE RE-ENTRY IN 3D HUMAN NEURON CULTURES	201901159349300235
2018	Beth Israel Deaconess Medical Center Boston, MA	A	$209,725	paid	UTILIZING FUNCTIONAL MAPS TO PRIORITIZE THERAPEUTIC TARGETS IN AD	201901159349300235
2018	University of North Carolina at Charlotte Charlotte, NC	B	$200,000	paid	STUDY OF REACTIVE ASTROCYTES DERIVED OXIDATIVE STRESS AND MICROGLIAL NEURODEGENERATIVE INFLAMMATION IN AD	201901159349300235
2018	Carnegie Mellon University Pittsburgh, PA	A	$198,021	paid	CIRCUITS: INTERPRETING ALZHEIMER'S DISEASE-ASSOCIATED GENETIC VARIATION AT ENHANGER REGION	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$193,890	paid	GENES TO THERAPIES CENTRALIZED RESEARCH CORE	201901159349300235
2018	Whitehead Institute for Biomedical Research Cambridge, MA	A	$178,250	paid	WHOLE GENOME CHARACTERIZATION OF DNA METHYLATION CHANGES IN THE AGED AND AD	201901159349300235
2018	University of Connecticut Health Center Farmington, CT	U	$172,500	paid	PHYSIOLOGICAL METHOD FOR EARLY DETECTION OF SYNAPTIC VULNERABILITY IN AD MODEL ANIMALS	201901159349300235
2018	Northwestern University Evanston, IL	A	$172,500	paid	THE ROLE OF IMPAIRED SYNAPTIC VESICLE MACHINERY PROTEOSTATSIS IN ALZHEIMER'S DISEASE PATHOGENESIS	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$172,500	paid	IMAGING MICROGLIAL HOMEOSTASIS AND DISRUPTION P2RY12 RADIOTRACER DEVELOPMENT	201901159349300235
2018	The University of California San Diego La Jolla, CA	U	$172,500	paid	IDENTIYING THE BLOOD BRAIN BARRIER CHANGES DURING AD	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$172,500	paid	THE IMPACT OF AD-ASSOCIATED GENETIC VARIANTS IN 3D HUMAN MIXED NEURALGLIAL MODELS OF AD	201901159349300235
2018	Weill Medical College of Cornell University New York, NY	U	$172,500	paid	DIETARY SALT TAU PHOSPHRYLATION AND COGNITIVE IMPAIRMENT	201901159349300235
2018	Palo Alto Veterans Institute for Research Palo Alto, CA	A	$172,500	paid	REJUVENATION OF MICROGLIA IN BRAIN AGING AND NEURODEGENERATION	201901159349300235
2018	The Trustees of Boston University Boston, MA	A	$172,500	paid	AD PHARMACOMICS IN 3D	201901159349300235
2018	The Regents of the University of California Oakland, CA	A	$172,500	paid	HUMAN-SPECIFIC EVOLUTION OF CD33: EVOLUTIONARY RELATIONSHIP TO ANCIENT HOST-PATHOGEN INTERACTIONS AND CURRENT IMPLICATION FOR ALZHEIMER'S DISEASE	201901159349300235
2018	Yale University New Haven, CT	A	$172,500	paid	ROLE OF MICROGLIAL PROTEIN SPARC IN CONTROL OF INFLAMMASOME ACTIVATION	201901159349300235
2018	The Rockefeller University New York, NY	A	$172,500	paid	YEAR 1: THE DEVELOPMENT OF DNA-ENCODED LIBRARIES TO DISCOVER THERAPEUTICALLY VALUABLE LOW MOLECULAR WEIGHT COMPOUNDS FOR AD	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$172,500	paid	INHIBITING CD33 FUNCTION AND MODULATING MICROGLIAL ACTIVATION STATE FOR ALZHEIMER'S DISEASE THERAPY	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$172,500	paid	THE ROLE OF NEUREXINS IN ALZHEIMER'S DISEASE	201901159349300235
2018	The Trustees of Boston University Boston, MA	A	$172,500	paid	EVALUATION OF THE EFFECT OF CELL TYPE- SPECIFIC DELETION OF ESCRT GENES ON THE SPREAD OF TAU PATHOLOGY	201901159349300235
2018	Washington University St Louis St Louis, MO	U	$172,500	paid	CENTRAL CLOCK INFLUENCE ON ALZHEIMER'S DISEASE PATHOGENESIS	201901159349300235
2018	Mayo Clinic Rochester, MN	A	$172,500	paid	SENESCENT CELLS AND ALZHEIMER'S DISEASE	201901159349300235
2018	Washington University St Louis St Louis, MO	U	$172,500	paid	MODELING AD IN SPECIFIC SUBTYPES OF HUMAN NEURONS THROUGH THE DIRECT NEURONAL REPROGRAMMING	201901159349300235
2018	Yale University New Haven, CT	A	$172,500	paid	THE NEUROPROTECTIVE GLIAL BARRIER: A MULTICELLULAR REACTION WITH THERAPEUTIC POTENTIAL IN AD	201901159349300235
2018	University of Texas Southwestern Medical Center Dallas, TX	A	$172,500	paid	GENETIC TARGETS TO BLOCK TAU PROPAGATION: TEST KNOCKDOWN OF HSPG GENES IN VIVO	201901159349300235
2018	University of Southern California Los Angeles, CA	A	$172,500	paid	TARGETING BENEFICIAL INNATE IMMUNITY IN AD BY IRAK-M DELETION	201901159349300235
2018	Harvard College Boston, MA	A	$172,500	paid	ACTIVATION OF THE 26S PROTEASOME FOR THE TREATMENT OF ALZHEIMER'S DISEASE	201901159349300235
2018	Washington University St Louis St Louis, MO	U	$172,137	paid	THE CIRCADIAN CLOCK MODULATES NEURODENERATION IN AD VIA REVE-ERB	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$171,932	paid	INTERLEUKIN-3 IN AD	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$170,907	paid	EFFECTS OF CEREBROVASCULAR INSUFFICIENCY AND EXERCISE ON THE ALZHEIMER'S BRAIN	201901159349300235
2018	Weill Medical College of Cornell University New York, NY	U	$170,861	paid	AD RISK IS HIGHER IN WOMEN: IDENTIFICATION OF FEMALE SPECIFIC BRAIN BIOENERGETIC TARGETS	201901159349300235
2018	The Trustees of Tufts College Medford, MA	C	$150,000	paid	FUNCTIONAL CHARACTERIZATION OF GGA3 MUTATIONS ASSOCIATED WITH AD	201901159349300235
2018	The Rockefeller University New York, NY	A	$150,000	paid	STRICKLAND NORRIS YEAR 2: THE ROLE OF THE CONTACT SYSTEM IN AD	201901159349300235
2018	Columbia University New York, NY	A	$150,000	paid	NOVEL CHEMICAL MODULATION FOR BRACE 1-MEDIATED CLEAVAGE OF B-AMYLOID PRECURSOR PROTEIN	201901159349300235
2018	The Salk Institute for Biological Studies La Jolla, CA	A	$150,000	paid	MICROGLIAL TAM RECEPTORS AS MODULATORS OF AD	201901159349300235
2018	Boston Childrens Hospital Boston, MA	A	$149,999	paid	TEMPORAL ANALYSIS OF INFECTION IN ALZHEIMER'S DISEASE MODELS	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$148,732	paid	CIRCUITS: IPS CELLS AND THE HUMAN BRAINS	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$143,750	paid	INDENTIFYING BLOOD-BRAIN BARRIER ENHANCERS AND ROLE OF NEUTROPHILS IN A 3D BBB VASCULARIZED MODEL OF ALZHEIMER'S DISEASE	201901159349300235
2018	Massachusetts Institute of Technology Cambridge, MA	A	$125,000	paid	IDENTIFYING BLOOD-BRAIN BARRIER ENHANCERS AND ROLE OF NEUTROPHILS IN A BB VASCULARIZED MODEL OF ALZHEIMER'S DISEASE	201901159349300235
2018	The Salk Institute for Biological Studies La Jolla, CA	A	$109,250	paid	WHOLE GENOME CHARACTERIZATION OF DNA METHYLATION CHANGES IN THE AGED AND AD	201901159349300235
2018	The Regents of the University of California Oakland, CA	A	$100,479	paid	ABETA MEDIATED INHIBITION OF GAMMA-SECRETASE ACTIVITY INDUCES AD-RELEVANT CELLULAR PHENOTYPES MOBLEY	201901159349300235
2018	Massachusetts General Hospital Boston, MA	A	$100,000	paid	NEUROIMMUNE MOLECULAR IMAGING: REDEFINING THE LANDSCAPE OF OPPORTUNITIES IN AD	201901159349300235
2018	Washington University St Louis St Louis, MO	U	$79,594	paid	SCIENTIFIC DIRECTIONS FOR THE EXPLORATIONS OF RACIAL DISPARITIES IN AD	201901159349300235

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.